{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:42:42Z","timestamp":1792640562357,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["P30DA013429"],"award-info":[{"award-number":["P30DA013429"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.brainres.2021.147770","type":"journal-article","created":{"date-parts":[[2021,12,31]],"date-time":"2021-12-31T10:26:34Z","timestamp":1640946394000},"page":"147770","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Nicotine-induced C-shape movements in planarians are reduced by antinociceptive drugs: Implications for pain in planarian paroxysm etiology?"],"prefix":"10.1016","volume":"1778","author":[{"given":"Anthony","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott M.","family":"Rawls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.brainres.2021.147770_b0005","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1038\/s41593-017-0005-0","article-title":"Activation of planarian TRPA1 by reactive oxygen species reveals a conserved mechanism for animal nociception","volume":"20","author":"Arenas","year":"2017","journal-title":"Nat. Neurosci."},{"issue":"632","key":"10.1016\/j.brainres.2021.147770_b0010","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.neulet.2016.09.005","article-title":"Cotinine antagonizes the behavioral effects of nicotine exposure in the planarian Girardia tigrina","volume":"6","author":"Bach","year":"2016","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2021.147770_b0015","series-title":"Tobacco Use Disorder and Cardiovascular Health","author":"Benowitz","year":"2021"},{"issue":"1","key":"10.1016\/j.brainres.2021.147770_b0020","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3390\/ijms22010229","article-title":"Calmodulin Supports TRPA1 Channel Association with Opioid Receptors and Glutamate NMDA Receptors in the Nervous Tissue","volume":"22","author":"Cort\u00e9s-Montero","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"386","key":"10.1016\/j.brainres.2021.147770_b0025","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.neuroscience.2018.06.029","article-title":"Mu Opioid Receptor Agonist DAMGO Produces Place Conditioning, Abstinence-induced Withdrawal, and Naltrexone-Dependent Locomotor Activation in Planarians","volume":"21","author":"Dziedowiec","year":"2018","journal-title":"Neuroscience"},{"issue":"6971","key":"10.1016\/j.brainres.2021.147770_b0030","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/nature02282","article-title":"Mustard oils and cannabinoids excite sensory nerve fibres through the TRP channel ANKTM1","volume":"427","author":"Jordt","year":"2004","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.brainres.2021.147770_b0035","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3390\/ph11040117","article-title":"TRPA1 Antagonists for Pain Relief","volume":"11","author":"Koivisto","year":"2018","journal-title":"Pharmaceuticals (Basel)."},{"issue":"5","key":"10.1016\/j.brainres.2021.147770_b0040","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0165-6147(92)90060-J","article-title":"Drugs of abuse: anatomy, pharmacology and function of reward pathways","volume":"13","author":"Koob","year":"1992","journal-title":"Trends Pharmacol. Sci."},{"issue":"5","key":"10.1016\/j.brainres.2021.147770_b0045","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.neuron.2010.04.030","article-title":"A gain-of-function mutation in TRPA1 causes familial episodic pain syndrome","volume":"66","author":"Kremeyer","year":"2010","journal-title":"Neuron"},{"issue":"11","key":"10.1016\/j.brainres.2021.147770_b0050","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1097\/00001756-200008030-00033","article-title":"Reinforcing effects of methamphetamine in planarians","volume":"11","author":"Kusayama","year":"2000","journal-title":"NeuroReport"},{"issue":"6","key":"10.1016\/j.brainres.2021.147770_b0055","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/FBP.0000000000000236","article-title":"Benzodiazepine inhibits anxiogenic-like response in cocaine or ethanol withdrawn planarians","volume":"27","author":"Nayak","year":"2016","journal-title":"Behav. Pharmacol."},{"issue":"1","key":"10.1016\/j.brainres.2021.147770_b0060","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.neuroscience.2010.03.038","article-title":"Analysis of motor function modulated by cholinergic neurons in planarian Dugesia japonica","volume":"168","author":"Nishimura","year":"2010","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.brainres.2021.147770_b0065","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.neulet.2012.07.052","article-title":"In vivo comparison of harmine efficacy against psychostimulants: preferential inhibition of the cocaine response through a glutamatergic mechanism","volume":"525","author":"Owaisat","year":"2012","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/j.brainres.2021.147770_b0070","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.pbb.2007.12.008","article-title":"Reversal of cocaine-induced planarian behavior by parthenolide and related sesquiterpene lactones","volume":"89","author":"Pag\u00e1n","year":"2008","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"1-3","key":"10.1016\/j.brainres.2021.147770_b0075","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ejphar.2009.05.022","article-title":"A cembranoid from tobacco prevents the expression of nicotine-induced withdrawal behavior in planarian worms","volume":"615","author":"Pag\u00e1n","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainres.2021.147770_b0080","series-title":"The first Brain: The neuroscience of planarians","author":"Pagan","year":"2014"},{"issue":"1","key":"10.1016\/j.brainres.2021.147770_b0085","first-page":"41","article-title":"A pharmacological study of cocaine activity in planaria","volume":"115","author":"Palladini","year":"1996","journal-title":"Comp. Biochem. Physiol. C: Pharmacol. Toxicol. Endocrinol."},{"key":"10.1016\/j.brainres.2021.147770_b0095","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.pbb.2013.09.012","article-title":"Opioid receptor types involved in the development of nicotine physical dependence in an invertebrate (Planaria) model","volume":"112","author":"Raffa","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"1-3","key":"10.1016\/j.brainres.2021.147770_b0100","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ejphar.2010.09.021","article-title":"Topiramate-antagonism of L-glutamate-induced paroxysms in planarians","volume":"649","author":"Raffa","year":"2010","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.brainres.2021.147770_b0105","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.pbb.2011.06.003","article-title":"Carbamazepine inhibits distinct chemoconvulsant-induced seizure-like activity in Dugesia tigrina","volume":"99","author":"Ramakrishnan","year":"2011","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"208","key":"10.1016\/j.brainres.2021.147770_b0110","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.neuroscience.2012.01.019","article-title":"Mephedrone (\u201cbath salt\u201d) pharmacology: insights from invertebrates","volume":"19","author":"Ramoz","year":"2012","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/j.brainres.2021.147770_b0115","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/j.neuroscience.2010.06.041","article-title":"\u03b2-lactamase inhibitors display anti-seizure properties in an invertebrate assay","volume":"169","author":"Rawls","year":"2010","journal-title":"Neuroscience"},{"issue":"2-3","key":"10.1016\/j.brainres.2021.147770_b0120","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.drugalcdep.2011.04.001","article-title":"Nicotine behavioral pharmacology: clues from planarians","volume":"118","author":"Rawls","year":"2011","journal-title":"Drug Alcohol Depend."},{"issue":"4","key":"10.1016\/j.brainres.2021.147770_b0125","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.pbb.2009.05.005","article-title":"Topiramate antagonizes NMDA- and AMPA-induced seizure-like activity in planarians","volume":"93","author":"Rawls","year":"2009","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"2","key":"10.1016\/j.brainres.2021.147770_b0130","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.bjoms.2013.11.003","article-title":"Is nicotine still the bad guy? Summary of the effects of smoking on patients with head and neck cancer in the postoperative period and the uses of nicotine replacement therapy in these patients","volume":"52","author":"Reuther","year":"2014","journal-title":"Br. J. Oral Maxillofac. Surg."},{"issue":"12","key":"10.1016\/j.brainres.2021.147770_b0135","doi-asserted-by":"crossref","first-page":"e0226104","DOI":"10.1371\/journal.pone.0226104","article-title":"Pharmacological or genetic targeting of Transient Receptor Potential (TRP) channels can disrupt the planarian escape response","volume":"14","author":"Sabry","year":"2019","journal-title":"PLoS ONE"},{"issue":"10","key":"10.1016\/j.brainres.2021.147770_b0145","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1038\/nn.2379","article-title":"Nicotine activates tchemosensory cation channel TRPA1","volume":"12","author":"Talavera","year":"2009","journal-title":"Nat. Neurosci."},{"issue":"1-3","key":"10.1016\/j.brainres.2021.147770_b0150","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.drugalcdep.2009.12.014","article-title":"On deriving the dose-effect relation of an unknown second component: an example using buprenorphine preclinical data","volume":"109","author":"Tallarida","year":"2010","journal-title":"Drug Alcohol Depend."},{"issue":"11","key":"10.1016\/j.brainres.2021.147770_b0155","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1177\/1947601912440575","article-title":"Quantitative methods for assessing drug synergism","volume":"2","author":"Tallarida","year":"2011","journal-title":"Genes Cancer."},{"issue":"6","key":"10.1016\/j.brainres.2021.147770_b0160","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1007\/s00726-011-1052-6","article-title":"Glutamate carboxypeptidase II (GCPII) inhibitor displays anti-glutamate and anti-cocaine effects in an invertebrate assay","volume":"42","author":"Tallarida","year":"2012","journal-title":"Amino Acids"},{"issue":"6","key":"10.1016\/j.brainres.2021.147770_b0165","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.alcohol.2014.07.006","article-title":"Ethanol and cocaine: environmental place conditioning, stereotypy, and synergism in planarians","volume":"48","author":"Tallarida","year":"2014","journal-title":"Alcohol."},{"key":"10.1016\/j.brainres.2021.147770_b0170","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.neuropharm.2014.11.010","article-title":"Stereochemistry and neuropharmacology of a 'bath salt' cathinone: S-enantiomer of mephedrone reduces cocaine-induced reward and withdrawal in invertebrates","volume":"91","author":"Vouga","year":"2015","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.brainres.2021.147770_b0175","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.pharep.2015.11.008","article-title":"Potential role of spinal TRPA1 channels in antinociceptive tolerance to spinally administered morphine","volume":"68","author":"Wei","year":"2016","journal-title":"Pharmacol. Rep."},{"issue":"112\u2013113","key":"10.1016\/j.brainres.2021.147770_b0185","first-page":"8","article-title":"Sucrose produces withdrawal and dopamine-sensitive reinforcing effects in planarians","volume":"15","author":"Zhang","year":"2013","journal-title":"Physiol. Behav."},{"issue":"6","key":"10.1016\/j.brainres.2021.147770_b0190","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/s41416-020-0730-0","article-title":"Nicotine exposure potentiates lung tumorigenesis by perturbing cellular surveillance","volume":"122","author":"Zhang","year":"2020","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.brainres.2021.147770_b0195","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1124\/jpet.103.054775","article-title":"Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors","volume":"307","author":"Zhao","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"703","key":"10.1016\/j.brainres.2021.147770_b0090","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.neulet.2019.03.024","article-title":"Preliminary evidence from planarians that cotinine establishes a conditioned place preference","volume":"11","author":"Phelps","year":"2019","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2021.147770_b0140","doi-asserted-by":"crossref","first-page":"173075","DOI":"10.1016\/j.pbb.2020.173075","article-title":"Nicotine chronic tolerance development and withdrawal in the planaria (Schmidtea mediterranea)","volume":"200","author":"Sal","year":"2021","journal-title":"Pharmacol. Biochem. Behav."}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899321006296?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899321006296?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T18:19:49Z","timestamp":1757787589000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899321006296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":38,"alternative-id":["S0006899321006296"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2021.147770","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nicotine-induced C-shape movements in planarians are reduced by antinociceptive drugs: Implications for pain in planarian paroxysm etiology?","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2021.147770","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"147770"}}